• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双胎妊娠中游离胎儿DNA(cffDNA)用于21、18和13三体的大规模平行测序(MPS)

Massively Parallel Sequencing (MPS) of Cell-Free Fetal DNA (cffDNA) for Trisomies 21, 18, and 13 in Twin Pregnancies.

作者信息

Du Erqiu, Feng Chun, Cao Yuming, Yao Yanru, Lu Jing, Zhang Yuanzhen

机构信息

Department of Obstetrics and Gynecology,Zhongnan Hospital of Wuhan University,Wuhan,China.

出版信息

Twin Res Hum Genet. 2017 Jun;20(3):242-249. doi: 10.1017/thg.2017.23. Epub 2017 May 9.

DOI:10.1017/thg.2017.23
PMID:28485265
Abstract

Massively parallel sequencing (MPS) technology has become increasingly available and has been widely used to screen for trisomies 21, 18, and 13 in singleton pregnancies. This study assessed the performance of MPS testing of cell-free fetal DNA (cffDNA) from maternal plasma for trisomies 21, 18, and 13 in twin pregnancies. Ninety-two women with twin pregnancies were recruited. The results were identified through karyotypes of amniocentesis or clinical examination and follow-up of the neonates. Fluorescent in-situ hybridization was used to examine the placentas postnatally in cases of false-positive results. The fetuses with autosomal trisomy 21 (n = 2) and trisomy 15 (n = 1) were successfully detected via MPS testing of cffDNA. There was one false-positive for trisomy 13 (n = 1), and fluorescence in-situ hybridization (FISH) identified confined placental mosaicism in this case. For twin pregnancies undergoing second-trimester screening for trisomy, MPS testing of cffDNA is feasible and can enhance the diagnostic spectrum of non-invasive prenatal testing, which could effectively reduce invasive prenatal diagnostic methods. In addition to screening for trisomy 21, 18, and 13 by cffDNA, MPS can detect fetal additional autosomal trisomy. False-positive results cannot completely exclude confined placental mosaicism.

摘要

大规模平行测序(MPS)技术已越来越普及,并已广泛用于单胎妊娠中21、18和13三体综合征的筛查。本研究评估了对双胎妊娠孕妇血浆中游离胎儿DNA(cffDNA)进行MPS检测用于21、18和13三体综合征筛查的性能。招募了92例双胎妊娠妇女。通过羊膜穿刺术的核型分析或临床检查及新生儿随访来确定结果。对于假阳性结果的病例,产后采用荧光原位杂交技术检查胎盘。通过对cffDNA进行MPS检测成功检测出2例21三体胎儿和1例15三体胎儿。有1例假阳性的13三体(n = 1),荧光原位杂交(FISH)在该病例中确定为局限性胎盘嵌合体。对于接受孕中期三体综合征筛查的双胎妊娠,对cffDNA进行MPS检测是可行的,并且可以扩大无创产前检测的诊断范围,从而有效减少侵入性产前诊断方法。除了通过cffDNA筛查21、18和13三体综合征外,MPS还可以检测胎儿额外的常染色体三体。假阳性结果不能完全排除局限性胎盘嵌合体。

相似文献

1
Massively Parallel Sequencing (MPS) of Cell-Free Fetal DNA (cffDNA) for Trisomies 21, 18, and 13 in Twin Pregnancies.双胎妊娠中游离胎儿DNA(cffDNA)用于21、18和13三体的大规模平行测序(MPS)
Twin Res Hum Genet. 2017 Jun;20(3):242-249. doi: 10.1017/thg.2017.23. Epub 2017 May 9.
2
Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.双胎妊娠胎儿三体的常规早孕期筛查:游离 DNA 检测取决于联合检测的结果。
Ultrasound Obstet Gynecol. 2019 Feb;53(2):208-213. doi: 10.1002/uog.20160. Epub 2018 Dec 7.
3
Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.应用 IONA 测试的双胎妊娠游离胎儿 DNA 非侵入性产前筛查:一项前瞻性多中心研究。
Am J Obstet Gynecol. 2021 Jul;225(1):79.e1-79.e13. doi: 10.1016/j.ajog.2021.01.005. Epub 2021 Jan 15.
4
Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.基于大型转诊基因诊断实验室数据的无细胞非侵入性产前筛查的阳性预测值估计
Am J Obstet Gynecol. 2017 Dec;217(6):691.e1-691.e6. doi: 10.1016/j.ajog.2017.10.005. Epub 2017 Oct 13.
5
Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study.游离胎儿 DNA 筛查在双胞胎妊娠 21 三体中的应用:一项大型多中心队列研究。
Am J Obstet Gynecol. 2023 Oct;229(4):435.e1-435.e7. doi: 10.1016/j.ajog.2023.04.002. Epub 2023 Apr 6.
6
Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy.母体外周血游离胎儿 DNA 分析在双胎妊娠中作为 21、18 和 13 三体的筛查试验。
Ultrasound Obstet Gynecol. 2018 Sep;52(3):318-324. doi: 10.1002/uog.18838. Epub 2018 Aug 13.
7
Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.在中国一个试点城市,非侵入性产前检测在 21 三体、18 三体、13 三体和性染色体非整倍体的一线筛查中表现出良好的临床性能。
Hum Genomics. 2020 Jun 5;14(1):21. doi: 10.1186/s40246-020-00268-2.
8
The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.游离循环肿瘤 DNA 与无创性产前检测结果联合应用于乳腺癌的模拟研究
DNA Cell Biol. 2018 Jul;37(7):626-633. doi: 10.1089/dna.2017.4112. Epub 2018 Jun 29.
9
Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies.应用无创产前检测技术筛查双胎妊娠胎儿染色体非整倍体疾病。
Expert Rev Mol Diagn. 2019 Feb;19(2):189-196. doi: 10.1080/14737159.2019.1562906. Epub 2019 Jan 2.
10
Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies.通过对双胎妊娠孕妇血浆DNA进行大规模平行测序对21三体和18三体进行无创产前检测。
Prenat Diagn. 2014 Apr;34(4):335-40. doi: 10.1002/pd.4303. Epub 2014 Feb 3.

引用本文的文献

1
Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions.无创产前检测(NIPT):可靠性、挑战与未来方向。
Diagnostics (Basel). 2023 Aug 2;13(15):2570. doi: 10.3390/diagnostics13152570.
2
Non-invasive prenatal test to screen common trisomies in twin pregnancies.用于筛查双胎妊娠常见三体综合征的无创产前检测
Mol Cytogenet. 2020 Feb 5;13:5. doi: 10.1186/s13039-020-0475-8. eCollection 2020.
3
Non-invasive Prenatal Diagnosis of Chromosomal Aneuploidies and Microdeletion Syndrome Using Fetal Nucleated Red Blood Cells Isolated by Nanostructure Microchips.
利用纳米结构微芯片分离胎儿有核红细胞进行非侵入性产前诊断染色体非整倍体和微缺失综合征。
Theranostics. 2018 Feb 2;8(5):1301-1311. doi: 10.7150/thno.21979. eCollection 2018.